Effects of Broad Spectrum Antibiotics on Measurement of Immunosuppressant Drugs.

Q2 Medicine
Ataman Gönel, Idris Kirhan
{"title":"Effects of Broad Spectrum Antibiotics on Measurement of Immunosuppressant Drugs.","authors":"Ataman Gönel,&nbsp;Idris Kirhan","doi":"10.2174/1871523019666200324111436","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Antibiotics used parenterally can affect blood drug level measurements, as measured in diagnostic tests.</p><p><strong>Objective: </strong>To investigate the effect of six different antibiotics commonly used in intensive care units on tacrolimus, sirolimus, everolimus and cyclosporin A levels measured by mass spectrometry.</p><p><strong>Methods: </strong>Ampicillin + sulbactam (AB1, IV, 1 g), imipenem + cilastatin sodium (AB2, IV, 500 mg), piperacillin + tazobactam (AB3, 4.5 g, IV), ertapenem (AB4, IV, 1 g), meropenem trihydrate (AB5, 500 mg, IV) and ceftriaxone (AB6, 1 g, IV) antibiotics were used for the interference assay. Measurements were performed on the Shimadzu 8045 (Japan) LC-MS/MS instrument. Bias values were calculated.</p><p><strong>Results: </strong>The least affected immunosuppressant was cyclosporine A (between -6.88% and 3.40%). The most affected were everolimus and sirolimus. Ertapenem caused negative interference on the level of everolimus at the rate of -27.34% and sirolimus at the rate of -26.79%. Piperacillin + tazobactam and imipenem + cilastatin sodium caused positive interferences on sirolimus at the rate of 24.24% and 22.73%, respectively. Ampicillin + sulbactam, meropenem trihydrate and ceftriaxone affected the sirolimus levels at lower rates (-4.49%, 5.93% and 9.86%). Everolimus levels deviated at the rate of -11.21% to -16.99% due to imipenem + cilastatin sodium, meropenem trihydrate and ceftriaxone.</p><p><strong>Conclusion: </strong>This study demonstrated the potential of antibiotic use affecting immunosuppressant levels. Antibiotic interference, especially in transplant patients, may cause erroneous immunosuppression, increasing the likelihood of rejection.</p>","PeriodicalId":35423,"journal":{"name":"Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1871523019666200324111436","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Antibiotics used parenterally can affect blood drug level measurements, as measured in diagnostic tests.

Objective: To investigate the effect of six different antibiotics commonly used in intensive care units on tacrolimus, sirolimus, everolimus and cyclosporin A levels measured by mass spectrometry.

Methods: Ampicillin + sulbactam (AB1, IV, 1 g), imipenem + cilastatin sodium (AB2, IV, 500 mg), piperacillin + tazobactam (AB3, 4.5 g, IV), ertapenem (AB4, IV, 1 g), meropenem trihydrate (AB5, 500 mg, IV) and ceftriaxone (AB6, 1 g, IV) antibiotics were used for the interference assay. Measurements were performed on the Shimadzu 8045 (Japan) LC-MS/MS instrument. Bias values were calculated.

Results: The least affected immunosuppressant was cyclosporine A (between -6.88% and 3.40%). The most affected were everolimus and sirolimus. Ertapenem caused negative interference on the level of everolimus at the rate of -27.34% and sirolimus at the rate of -26.79%. Piperacillin + tazobactam and imipenem + cilastatin sodium caused positive interferences on sirolimus at the rate of 24.24% and 22.73%, respectively. Ampicillin + sulbactam, meropenem trihydrate and ceftriaxone affected the sirolimus levels at lower rates (-4.49%, 5.93% and 9.86%). Everolimus levels deviated at the rate of -11.21% to -16.99% due to imipenem + cilastatin sodium, meropenem trihydrate and ceftriaxone.

Conclusion: This study demonstrated the potential of antibiotic use affecting immunosuppressant levels. Antibiotic interference, especially in transplant patients, may cause erroneous immunosuppression, increasing the likelihood of rejection.

广谱抗生素对免疫抑制药物测定的影响。
背景:经肠外使用的抗生素可影响诊断试验中测定的血药水平。目的:探讨重症监护病房常用的6种抗生素对他克莫司、西罗莫司、依维莫司及环孢素A含量的影响。方法:采用氨苄西林+舒巴坦(AB1, IV, 1 g)、亚胺培南+西司他汀钠(AB2, IV, 500 mg)、哌拉西林+他唑巴坦(AB3, 4.5 g, IV)、厄他培南(AB4, IV, 1 g)、三水合美罗培南(AB5, 500 mg, IV)、头孢曲松(AB6, 1 g, IV)等抗生素进行干扰试验。在Shimadzu 8045(日本)LC-MS/MS仪器上进行测量。计算偏倚值。结果:环孢素A对免疫抑制剂的影响最小(-6.88% ~ 3.40%)。影响最大的是依维莫司和西罗莫司。厄他培南对依维莫司和西罗莫司的负干扰率分别为-27.34%和-26.79%。哌拉西林+他唑巴坦和亚胺培南+西司他汀钠对西罗莫司的正向干扰率分别为24.24%和22.73%。氨苄西林+舒巴坦、三水合美罗南和头孢曲松对西罗莫司的影响率较低(-4.49%、5.93%和9.86%)。由于亚胺培南+西司他汀钠、三水合美罗培南和头孢曲松,依维莫司水平偏离率为-11.21% ~ -16.99%。结论:本研究表明抗生素使用可能影响免疫抑制剂水平。抗生素干扰,特别是移植患者,可能导致错误的免疫抑制,增加排斥的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry
Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
3.30
自引率
0.00%
发文量
11
期刊介绍: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new anti-inflammatory & anti-allergy agents. Publishing a series of timely in-depth reviews written by leaders in the field covering a range of current topics, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信